A Category

Promising Phase 2 Trial Results for Pembrolizumab in Metastatic Brain Cancer

Summary: A phase 2 clinical trial of pembrolizumab has shown promising results, with 42% of patients with metastatic brain cancer benefiting from the treatment. The trial found that pembrolizumab, an immunotherapy, was tolerated and demonstrated clinical benefit in patients with brain metastases. The study’s authors caution that the therapy’s benefits must be balanced against toxicity…

South America: A hard road to unity | Politics News

Unlike other parts of the world, Latin America is free of war. Yet it is a region plagued by inequality, crime, corruption, drug trafficking and social upheaval. Political stability and strong democratic institutions are more the exception than the rule. South America, in particular, never seems to stop moving from one extreme to the other,…


More Articles